Berg Diagnostics

BERG is a clinical-stage, AI-powered biotech company that utilizes its proprietary platform, Interrogative Biology®, to map diseases and revolutionize treatments for cancer, neurological disorders, and rare diseases. By adopting a Back to Biology™ approach, BERG can identify key biomarkers that accelerate the discovery and development of treatments targeting the most promising therapeutic targets and pathways. BERG has leveraged both Interrogative Biology® and traditional R&D methods to develop first-in-class product candidates and advance a robust pipeline of bold, innovative diagnostics with the potential to improve patient lives.